Long-Term Safety and Tolerability of ABT-126 in Subjects with Mild-to-Moderate Alzheimer�s Disease: An Open-Label Extension Study for Subjects Completing Study M10-985.
Read time: 1 mins
Last updated:15th May 2012
The objective of this study is to evaluate the long-term safety and tolerability of ABT-126 in subjects with mild-to-moderate AD in a 28-week, open-label extension of Study M10-985.
|Study start date||2012-05-15|